Hemoglobin Switching Meeting Programs 1 – 21 Conferences (1978 – 2018)

Total Page:16

File Type:pdf, Size:1020Kb

Hemoglobin Switching Meeting Programs 1 – 21 Conferences (1978 – 2018) HEMOGLOBIN SWITCHING MEETING PROGRAMS 1ST – 21ST CONFERENCES (1978 – 2018) George Stamatoyannopoulos 1934-2018 FIRST CONFERENCE ON HEMOGLOBIN SWITCHING PART I. DEVELOPMENTAL HEMOGLOBINS IN MAN AND ANIMAL MODELS A. Human Fetal Hemoglobin Genetics of Fetal Hemoglobin Production in Adult Life D.J. Weatherall, W.G Wood & J. B. Clegg Human Gamma Chains: Structural Features W.A. Schroder & T.H.J. Huisman The in vivo Biology of F Cells in Man S.H. Boyer & G.J. Dover On the Origin of F Cells in the Adult: Clues from Studies in Clonal Hemopathies T. Papayannopoulou & G Stamatoyannopoulos Fetal Erythropoiesis in Bone Marrow Failure Syndromes B.P. Alter Age and Sex Effects on Hemoglobin F in Sickle Cell Anemia D.L. Rucknagel, S.H. Hanash, C.F. Sing, W.P. Winter, G.F. Whitten & A.S. Prasad Hemoglobin F and Thalassemia P. Fessas Fetal Hemoglobin in Women with Hydatidiform Molar Pregnancy J.C. Lee B. Physiology of Hemoglobin Switching Stimulation of Fetal Hemoglobin Synthesis Following Stress Erythropoiesis J. De Simone, P. Heller & S.I. Biel The Sheep as an Animal Model for the Switch from Fetal to Adult Hemoglobins W.G. Wood, J. Nash, D.J. Weatherall, J.S. Robinson & F.A. Harrison Effect of Thyroid Hormone on Erythropoiesis and the Switch from Fetal to Adult Hemoglobin Synthesis in Fetal Sheep E.D. Zanjani, B.J. Gormus, A. Bhathavathsalan, T.M. Engler, A.P. McHale & L.I. Mann Stimulation of Hemoglobin C Synthesis by Erythropoietin in Fetal and Neonatal Sheep J.E. Barker, J.E. Pierce & A.W. Nienhuis C. Hemoglobins in Early Development Determination and Differentiation in Early Embryonic Erythropoiesis: A New Experimental Approach V.M. Ingram, R.W. Kean & P.C. Lindblad Regulation of Embryonic and Adult Hemoglobin Synthesis in Chickens A.J. Tobin, B.S. Chapman, D.A. Hansen, L. Lasky & S.E. Selvig Hemoglobin Ontogeny in Fetal Mice: Adult Hemoglobin in Yolk Sac Derived Erythrocytes D.H.K. Chui, T.W. Brotherton & J. Gauldie Embryonic Hemoglobins in α-Thalassemia Mice R.A. Popp, B.S. Bradshaw & G.P. Hirsch Developmental Hemoglobins in the Hamster J.F. Bertles & T. Boussios PART II. HEMOGLOBIN SWITCHING AND ERYTHROID CELL DIFFERENTIATION D. Regulation of Erythropoiesis In Vitro Characterization of Erythroid Precursor Cells and the Erythropoietic Differentiation Process C.J. Eaves, R.K. Humphries & A.C. Eaves Interactions of Hematopoietic Cells M.J. Cline & D.W. Golde The Influence of T cells on Erythropoiesis D.G. Nathan, D.G. Hillman & J. Breard Hormonal Effects on Erythroid Stem Cells D.W. Golde, N. Bersch & M.J. Cline E. Hemoglobin Switching in Culture Fetal Hemoglobin and the Erythroid Stem Cell Differentiation Process G. Stamatoyannopoulos & T. Papayannopoulou Control of Fetal Hemoglobin Synthesis in Adult Erythroid Precursor Cells: Evidence for Different Programs for Bone Marrow and Peripheral Blood Precursors D. Housman, B. Clarke, D. Hillman, B. Alter, B. Forget & D. Nathan Preferential Synthesis of Fetal Hemoglobin in Culture by Human Erythropoietic Precursors in the Marrow and Blood M. Ogawa, K. Kidoguchi & J.D. Karam Distribution of Fetal Hemoglobin in Individual Colonies by RIA: A Lead Toward Human Stem Cells H.A. Messner & A.A. Fauser Hormonal Influences on Globin Chain Synthesis of Fetal Cord Blood BFU-E in vitro R. Hoffman, N. Dainiak, E. Coupal, L. Maffei, K. Ritchey & B.G. Forget Induction of Hemoglobin C Synthesis in Sheep: Characterization of the “Switching” Stem Cell A.W. Nienhuis, R.D. Croissant & J.E. Barker F. Commitment and Biochemical Differentiation of Erythroid Cells Commitment to Differentiation of Normal and Transformed Erythroid Precursors R.A. Rifkind, E. Fibach, G. Maniatis, R. Gamari & P.A. Marks Expression of Globin Genes During Induced Erythroleukemia Cell Differentiation P.A. Marks, R.A. Rifkind, A. Bank, M. Terada, R. Gambari, E. Fibach, G. Maniatis & R. Reuben Globin Synthesis in Mouse Erythroleukemia Cells: Effect of Various Inducers B.A. Alter A Model for Differentiation: Modification of Chromatin Proteins in Differentiating Erythroid and Nonerythroid Cells V.M. Ingram, H.K. Hagopian, M.G. Riggs, J.R. Neumann, M.E. Dobson, B.B. Owens & G.M. Maniatis PART III. MOLECULAR BIOLOGY OF HEMOGLOBIN SWITCHING G. Organization of Globin Genes The Organization of Mouse β-Globin Genes P. Leder, S. Tilghman, D. Tiemeier, D. Konkel, J.G. Seidman & H.I. Miller Isolation and Characterization of Mammalian Globin Genes E. Lacy, R.M. Lawn, E. Fritsch, R.C. Hardison, R.C. Parker & T. Maniatis Organization of the Human Globin Genes in Normal and Thalassemia Cells A. Bank, J.G. Mears & F. Ramirez Restriction Mapping of Human Globin Genes in Cellular DNA: The Organization of the Duplicated Alpha Loci S.H. Orkin The Map of Human γ-Globin Genes R. Williamson H. Globin mRNA Structure Globin mRNA Structure: General Features and Sequence Homology B.G. Forget, J.T. Wilson, L.B. Wilson, C. Cavallesco, V.B. Reddy, J.K. deRiel, A.P. Biro, P.K. Ghosh & S.M. Weissman Nucleotide Sequences of the Untranslated 5’ and 3’ Regions of Human α-, β- and γ-Globin mRNAs Y.W. Kan, J.C. Chang & R. Poon 5’-Terminal Modification of Globin Messenger RNA H.H. Kazazian Jr, T. Cheng & S. Cho Analysis of Chicken Globin cDNA Clones: Discovery of a Novel Chicken Alpha-Globin Gene Induced by Stress in Young Chickens W.A. Salser, I. Cummings, A. Liu, J. Strommer, J. Padayatty & P. Clarke I. Metabolism of Globin mRNA The Structure and Metabolism of the Precursors of Mouse α- and β-globin mRNAs J Ross, A.J. Kinniburgh & J.E. Mertz Processing and Turnover of Globin mRNA During Erythroid Maturation J.B. Lingrel, K. Lowenhaupt, J.R. Haynes, P. Rosteck Jr., V.F. Kalb Jr. & K. Smith Regulation of Embryonic Hemoglobin in Chickens L-N.L. Chan Regulation of the Individual Globin mRNAs During Hemoglobin Switching in Sheep E.J. Benz Jr., J.A. Kantor & A.W. Nienhuis J. Control of Globin Gene Expression Control of Globin Gene Expression H. Weintraub, M. Groudine, S. Weisbrod, D. Riley & I. Albanese Structure of the Individual Globin Genes in Chromatin N.S. Young, E.J. Benz Jr. & A. Nienhuis Study of Expression of Human Globin Genes in Hybrid Mouse Erythroleukemia Cells A. Deisseroth & D. Hendrick A New Approach in the Search for Globin Gene Regulatory Factors W.F. Anderson, M.C. Willing, D.E. Axelrod, T.V. Gopalakrishnan & E.G. Diacumakos The1st Hemoglobin Switching Meeting Battelle Institute Seattle: 1978 This conference was a small gathering (75 participants) of physicians, cell biologists, and molecular biologists . The program covered the whole field of hemoglobin switching as of 1978.. Erythropoiesis Structure of Globin Genes (mainly Southern Blotting) Chromatin Structure Hb Switching Cell, Vol . 15, 307-315, September 1978, Copyright © 1978 by MIT Hemoglobin Switching Meeting Review Arthur W . Nienhuis of Hb F (14-28% of total) and 24-27 pg of Hb A Clinical Hematology Branch (Boyer ; Johns Hopkins) ; 0 .2-7% of the red cells in National Heart, Lung and Blood Institute normal humans are F cells . In various heterocellu- Bethesda, Maryland 20014 lar HPFH syndromes (genetic states characterized George Stamatoyannopoulos by increased Hb F production in the absence of Medical Genetics other changes in the red cell) the number of F cells University of Washington is increased . Linkage analysis (Weatherall ; Oxford) Seattle, Washington 98195 appears to suggest that the gene for heterocellular HPFH is linked to the human y-5-/3 gene complex Introduction known to be on chromosone 11 (Deisseroth ; NIH) . In the Saudi Arabian population of patients with On June 19-21, 1978, a conference was held to sickle cell anemia, clinical manifestations are very review the current state of knowledge on the mech- mild and Hb F comprises 20-40% of the total anism of regulation of hemoglobin switching . The hemoglobin . Heterozygotes for the /3 gene in this transitions from embryonic to fetal (or adult) he- population have little increase in Hb F, excluding moglobin synthesis occurring early in embryogen- heterocellular HPFH as the basis for increased Hb esis and the transition from fetal to adult produc- F production in the SS individuals . The anemic tion at about the time of birth in several species stress due to sickle cell anemia brings out a pro- were discussed . These switches represent models pensity for Hb F production in this genetic isolate, in which one can examine the regulation of individ- in contrast to the much smaller amounts of Hb F ual globin genes both at the molecular level and seen in most black patients with SS disease . In during the various stages of cellular differentiation patients with homozygous /3 thalassemia, red cell that lead to production of red blood cells contain- production may be increased more than 25 fold . ing particular hemoglobins . The ability to stimulate The increase in Hb F may be accounted for by fetal hemoglobin (Hb F) production in adults might simple amplification of the F cell population, since be of therapeutic benefit in patients with sickle cell those cells containing Hb F have a selective advan- anemia or severe variants of homozygous /3 thal- tage both during erythropoiesis in the bone marrow assemia . In addition, certain mutations in humans and circulation of red cells in the blood stream . are characterized by enhanced production of Hb F . Thus a consideration of the various genetic con- Thus at this conference an effort was made to ditions which lead to increased Hb F production in examine the known clinical, genetic and experi- adults identifies several potential mechanisms: mental observations directly pertinent to various gene deletion, mutations in a regulatory locus developmental or physiological switches in hemo- linked to the y-5-/3 globin gene complex, activation globin phenotype, and to relate these data to re- of a latent potential for Hb F production by anemia, cent developments in cellular and molecular biol- or amplification of the normal F cell population by ogy, in an effort to develop a framework for the severe erythropoietic stress .
Recommended publications
  • Hemoglobin C Trait (AC) Hemoglobin Eletrophoresis and a Mean Corpuscular Volume
    Inheritance Pattern for SHOULD WE, THE PARENTS, TAKE A BLOOD TEST? Sickle Cell Disease - SC Before you have your next baby, we suggest that you and Hemoglobin your partner get special blood test. We all have two sets of genes for hemoglobin. One set is passed on to the baby When one parent has sickle cell trait (AS) and the from each parent. The testing should include, at minimum, a C Trait (AC) other has hemoglobin C trait (AC) hemoglobin eletrophoresis and a mean corpuscular volume. A sickle solubility test (sickledex) is not sufficient! & Your Baby Only if both you and your partner are tested can you know their baby exactly what kind of hemoglobin condition your next child A S may have A C could have. Look carefully at the inheritance pattern for the possibilities of having a baby with the SC form of sickle cell disease. A A A counselor can tell you if any of your future children could have a form of sickle cell disease. AA (normal hemoglobin) For more information or Contact your local SCDAA organization or other health A C agency at: AC (hemoglobin C trait) or A S Or contact the SCDAA National Office at the address and AS (sickle cell trait) or telephone number below. Stay connected with Get Connected the first patient powered registry S C SC (a type of sickle cell disease) Register at www.getconnectedscd.com It does not matter what their other babies have, their Sickle Cell Disease next one has the same four possibilities: AA, AC, AS, or SC.
    [Show full text]
  • Front Matter (PDF)
    IMMUNOLOGYwww.jimmunol.org Volume 176 / No. 6 / March 15, 2006 OF OURNAL J THE IMMUNOLOGYProgram Issue2006 Co-sponsored by Sir Philip Cohen and Professor Dario Alessi of the MRC Protein Phosphorylation Unit, and Professor Doreen Cantrell, University of Dundee Symposium Location: Apex City Quay Hotel & Spa, Dundee, UK tel +44 (0) 1382 561600 AN INITIATIVE TO RECOGNISE & REWARD OUTSTANDING RESEARCH WITHIN THE CELL SIGNALLING AREA Submission Deadline: 31st March, 2006 The successful young scientist will receive reagents and support funding of £10,000/$17,000/€14,000 donated to their laboratory, a personal cash prize of £5,000/$8,500/€7,000, plus a trophy. IMMUNOLOGY 2006 Annual Meeting of The American Association of Immunologists May 12–16, 2006 Hynes Convention Center • Boston, MA ImportantImportant DeadlinesDeadlines EARLY REGISTRATION HOTEL RESERVATIONS VISA INFORMATION March 6, 2006 April 13, 2006 www.aai.org/Imm2006/TransVisas.htm For complete meeting information visit www.aai.org/Imm2006/default.htm AAI Program PRESIDENT’S PROGRAM President’s Symposium DISTINGUISHED LECTURES T Cell Recognition and Development President’s Address Supported through an unrestricted educa- Defining Yourself: Tolerance Development Monday, May 15, 2:30 PM tional grant from Genentech, Inc. Hynes Convention Center, Ballroom A/B in the Immune System Ronald N. Germain, NIAID, NIH Chair: Paul M. Allen, Washington Univ. Saturday, May 13, 5:00 PM Friday, May 12, 5:00 PM School of Medicine, AAI President Hynes Convention Center, Ballroom A/B Hynes Convention Center, Ballroom A/B Speakers Introduction: Emil R. Unanue A reconstructionist's view Philippa Marrack, HHMI, Washington Univ. School of Medicine of antigen-specific T cell National Jewish Med.
    [Show full text]
  • Professor Peter Goldreich Member of the Board of Adjudicators Chairman of the Selection Committee for the Prize in Astronomy
    The Shaw Prize The Shaw Prize is an international award to honour individuals who are currently active in their respective fields and who have recently achieved distinguished and significant advances, who have made outstanding contributions in academic and scientific research or applications, or who in other domains have achieved excellence. The award is dedicated to furthering societal progress, enhancing quality of life, and enriching humanity’s spiritual civilization. Preference is to be given to individuals whose significant work was recently achieved and who are currently active in their respective fields. Founder's Biographical Note The Shaw Prize was established under the auspices of Mr Run Run Shaw. Mr Shaw, born in China in 1907, was a native of Ningbo County, Zhejiang Province. He joined his brother’s film company in China in the 1920s. During the 1950s he founded the film company Shaw Brothers (HK) Limited in Hong Kong. He was one of the founding members of Television Broadcasts Limited launched in Hong Kong in 1967. Mr Shaw also founded two charities, The Shaw Foundation Hong Kong and The Sir Run Run Shaw Charitable Trust, both dedicated to the promotion of education, scientific and technological research, medical and welfare services, and culture and the arts. ~ 1 ~ Message from the Chief Executive I warmly congratulate the six Shaw Laureates of 2014. Established in 2002 under the auspices of Mr Run Run Shaw, the Shaw Prize is a highly prestigious recognition of the role that scientists play in shaping the development of a modern world. Since the first award in 2004, 54 leading international scientists have been honoured for their ground-breaking discoveries which have expanded the frontiers of human knowledge and made significant contributions to humankind.
    [Show full text]
  • Adult, Embryonic and Fetal Hemoglobin Are Expressed in Human Glioblastoma Cells
    514 INTERNATIONAL JOURNAL OF ONCOLOGY 44: 514-520, 2014 Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells MARWAN EMARA1,2, A. ROBERT TURNER1 and JOAN ALLALUNIS-TURNER1 1Department of Oncology, University of Alberta and Alberta Health Services, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada; 2Center for Aging and Associated Diseases, Zewail City of Science and Technology, Cairo, Egypt Received September 7, 2013; Accepted October 7, 2013 DOI: 10.3892/ijo.2013.2186 Abstract. Hemoglobin is a hemoprotein, produced mainly in Introduction erythrocytes circulating in the blood. However, non-erythroid hemoglobins have been previously reported in other cell Globins are hemo-containing proteins, have the ability to types including human and rodent neurons of embryonic bind gaseous ligands [oxygen (O2), nitric oxide (NO) and and adult brain, but not astrocytes and oligodendrocytes. carbon monoxide (CO)] reversibly. They have been described Human glioblastoma multiforme (GBM) is the most aggres- in prokaryotes, fungi, plants and animals with an enormous sive tumor among gliomas. However, despite extensive basic diversity of structure and function (1). To date, hemoglobin, and clinical research studies on GBM cells, little is known myoglobin, neuroglobin (Ngb) and cytoglobin (Cygb) repre- about glial defence mechanisms that allow these cells to sent the vertebrate globin family with distinct function and survive and resist various types of treatment. We have tissue distributions (2). During ontogeny, developing erythro- shown previously that the newest members of vertebrate blasts sequentially express embryonic {[Gower 1 (ζ2ε2), globin family, neuroglobin (Ngb) and cytoglobin (Cygb), are Gower 2 (α2ε2), and Portland 1 (ζ2γ2)] to fetal [Hb F(α2γ2)] expressed in human GBM cells.
    [Show full text]
  • Hemoglobin C Trait What Does This Mean for My Baby, Me and My Family?
    My Baby Has Hemoglobin C Trait What does this mean for my baby, me and my family? Your baby's newborn screening test showed tell them their chance to have a baby with a that he or she has hemoglobin C trait (this is hemoglobin disease. also referred to as being a “hemoglobin C carrier”). Babies who have hemoglobin C trait What does having a baby with hemoglobin are no more likely to get sick than any other C trait mean for me, my partner and for baby. They do not need any special medical future pregnancies? treatment. Hemoglobin C trait will not change Since your baby has hemoglobin C trait, this into a disease later on. means that either you or your partner or both of you have hemoglobin C trait. In almost all What causes hemoglobin C trait? cases, ONLY ONE OF YOU will have Hemoglobin C trait happens when the part of hemoglobin C trait. the red blood cell that carries oxygen throughout the body is changed. This part that Most people do not know that they have is changed is called hemoglobin. Hemoglobin hemoglobin C trait. Now that your baby is is important because it picks up oxygen in the known to have hemoglobin C trait, both you lungs and carries it to the other parts of the and your partner have the option of being body. tested. Testing involves a blood test. People usually have one type of hemoglobin. IF ONLY ONE OF YOU HAS HEMOGLOBIN This is called hemoglobin A. Babies with C TRAIT, in every pregnancy there is a: hemoglobin C trait have a second type of • 1 in 2 (50%) chance to have a baby with hemoglobin called hemoglobin C, as well as only the usual hemoglobin A.
    [Show full text]
  • Pathological Conditions Involving Extracellular Hemoglobin
    Pathological Conditions Involving Extracellular Hemoglobin: Molecular Mechanisms, Clinical Significance, and Novel Therapeutic Opportunities for alpha(1)-Microglobulin Gram, Magnus; Allhorn, Maria; Bülow, Leif; Hansson, Stefan; Ley, David; Olsson, Martin L; Schmidtchen, Artur; Åkerström, Bo Published in: Antioxidants & Redox Signaling DOI: 10.1089/ars.2011.4282 2012 Link to publication Citation for published version (APA): Gram, M., Allhorn, M., Bülow, L., Hansson, S., Ley, D., Olsson, M. L., Schmidtchen, A., & Åkerström, B. (2012). Pathological Conditions Involving Extracellular Hemoglobin: Molecular Mechanisms, Clinical Significance, and Novel Therapeutic Opportunities for alpha(1)-Microglobulin. Antioxidants & Redox Signaling, 17(5), 813-846. https://doi.org/10.1089/ars.2011.4282 Total number of authors: 8 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Issue 84 of the Genetics Society Newsletter
    JANUARY 2021 | ISSUE 84 GENETICS SOCIETY NEWS In this issue The Genetics Society News is edited by • Non-canonical Careers: Thinking Outside the Box of Academia and Industry Margherita Colucci and items for future • Celebrating the 35th anniversary of DNA fingerprinting issues can be sent to the editor by email • Genetics Society Summer Studentship Workshop 2020 to [email protected]. • 2020 Heredity best student-led paper prize winners The Newsletter is published twice a year, • Industrious Science: interview with Dr Paul Lavin with copy dates of July and January. Celebrating students’ achievements: 2020 Genetics Society Summer Studentship Workshop, 2020 Heredity best student-led paper prize. Page 30 A WORD FROM THE EDITOR A word from the editor Welcome to Issue 84 elcome to the latest issue of the Thinking Outside the Box of WGenetics Society Newsletter! Academia and Industry”. This little This issue is packed with great news vade mecum for careers in genetics of achievements and good science. The collects inspiring interviews led first Genetics Society virtual workshop by our very own Postgraduate for the 2020 Summer studentship saw Representative, Emily Baker. In exceptional contributions from the Emily’s words, these experiences attending students. You can read more “demonstrate how a PhD in genetics about participants’ experiences in the can be a platform for a career in just interviews with the talk’s winners in about anything. Pursuing a career the Feature section. in academia, industry, publishing or science communication could be for Many more prizes were awarded: you, but so could many others. Why Heredity journal announced the not take a career path less travelled 2020 Heredity best student-led paper by, it might make all the difference?” winners, and James Burgon’s Heredity podcast dedicated an episode to the Enjoy! first prize winner, with insights from Best wishes, Heredity Editor-in-Chief, Barbara Margherita Colucci Mable.
    [Show full text]
  • Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease
    Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease Samuel Charache, … , Richard J. Ugoretz, J. Richard Spurrell J Clin Invest. 1967;46(11):1795-1811. https://doi.org/10.1172/JCI105670. Research Article Hemoglobin C is less soluble than hemoglobin A in red cells, in hemolysates, and in dilute phosphate buffer. Its relative insolubility may be explained by electrostatic interactions between positively charged β6-lysyl groups and negatively charged groups on adjacent molecules. Red cells from patients with homozygous hemoglobin C (CC) disease exhibit aberrant physical properties which suggest that the cells are more rigid than normal erythrocytes. They pass through membrane filters less readily than normal red cells do, and their viscosity is higher than that of normal cells. Differences from normal cells are exaggerated if mean corpuscular hemoglobin concentration (MCHC) is increased, by suspension in hypertonic salt solution. Increased rigidity of CC cells, by accelerating their fragmentation, may be responsible for formation of microspherocytes. These small dense cells are exceptionally rigid, and probably are even more susceptible to fragmentation and sequestration. Rigidity of CC cells can be attributed to a “precrystalline” state of intracellular hemoglobin, in which crystallization does not occur, although the MCHC exceeds the solubility of hemoglobin in hemolysates. Find the latest version: https://jci.me/105670/pdf The Journal of Clinical Investigation Vol. 46, No. 11, 1967 Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease * SAMUEL CHARACHE, C. LOCKARD CONLEY, DAVID F. WAUGH, RICHARD J. UGORETZ,4 AND J. RICHARD SPURRELL WITH THE TECHNICAL ASSISTANCE OF ESTHER GAYLE (From the Department of Medicine, The Johns Hopkins University and Hospital, Baltimore, Maryland, and the Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts) Abstract.
    [Show full text]
  • DNA Replication
    Cold Spring Harbor Laboratory Press Fall 2013 Catalog TEXTBOOKS TABLE OF CONTENTS TEXTBOOKS Genome Science D1 Evolution D4 DNA Science D2 Epigenetics D5 Molecular Biology of the Gene, 7th Ed. D3 ADVANCED TEXTBOOKS Introduction to Protein-DNA Interactions D6 Angiogenesis D24 Bacterial Pathogenesis D7 The Biology of Alzheimer Disease D26 Cell Survival and Cell Death D8 Extracellular Matrix Biology D28 Cystic Fibrosis D9 HIV D29 DNA Repair , Mutagenesis, and Parkinson’s Disease D31 Other Responses to DNA Damage D10 Protein Synthesis and Translational Control D32 DNA Replication D11 Type 1 Diabetes D33 The Endoplasmic Reticulum D13 The Synapse D34 Hemoglobin and Its Diseases D14 Wnt Signaling D35 Immune Tolerance D16 An Introduction to Animal Behavior D37 Mitochondria D17 Means to an End D38 Signaling by Receptor Tyrosine Kinases D18 RNA Worlds D39 Transplantation D20 Yeast Intermediary Metabolism D40 Addiction D22 Price changes and sale prices on selected titles may not be reflected in this catalog. Please visit our website for current pricing www.cshlpress.org. Please visit our Sale Shelf for special discounts on selected items. www.cshlpress.org 1-855-452-6793 Cold Spring Harbor Laboratory Press Fall 2013 Catalog TEXTBOOKS TABLE OF CONTENTS ADVANCED TEXTBOOKS (Continued) Essentials of Glycobiology, Second Edition D41 A Genetic Switch D44 Untangling the Double Helix D42 Index (Subject Areas) D45 An Introduction to Nervous Systems D43 Price changes and sale prices on selected titles may not be reflected in this catalog. Please visit our website for current pricing www.cshlpress.org. Please visit our Sale Shelf for special discounts on selected items. www.cshlpress.org 1-855-452-6793 TEXTBOOKS Genome Science A Practical and Conceptual Introduction to Molecular Genetic Analysis in Eukaryotes By David Micklos, Cold Spring Harbor Laboratory, Bruce Nash, Cold Spring Harbor Laboratory, and Uwe Hilgert, University of Arizona enome Science is a textbook and laboratory manual for advanced secondary and post-sec - G ondary education.
    [Show full text]
  • Observations on the Minor Basic Hemoglobin Component in the Blood of Normal Individuals and Patients with Thalassemia
    Observations on the Minor Basic Hemoglobin Component in the Blood of Normal Individuals and Patients with Thalassemia H. G. Kunkel, … , U. Müller-Eberhard, J. Wolf J Clin Invest. 1957;36(11):1615-1625. https://doi.org/10.1172/JCI103561. Research Article Find the latest version: https://jci.me/103561/pdf OBSERVATIONS ON THE MINOR BASIC HEMOGLOBIN COMPONENT IN THE BLOOD OF NORMAL INDIVIDUALS AND PATIENTS WITH THALASSEMIA BY H. G. KUNKEL, R. CEPPELLINI, U. MULLER-EBERHARD, AND J. WOLF (From the Rockefeller Institute for Medical Research, and Institute for the Study of Human Variation, and the Departmet of Pediatrics, Colunma Uniewsity, N. Y.) (Submitted for publication March 6, 1957; accepted April 11, 1957) In a previous report (1) a second hemoglobin was collected from a number of New York hospitals. was described which was found at a concentration The specimens from patients with thalassemia were ob- of tained from Italian and Greek individuals in the hema- approximately 3 per cent in the blood of normal tology clinic at the Babies Hospital, Columbia-Presby- adult individuals. It was found to resemble he- terian Medical Center, New York. Five individuals with moglobin E in electrophoretic properties, but iden- thalassemia in two families were obtained from index tity with this abnormal hemoglobin was not estab- cases at Bellevue Hospital. The great majority of lished. This same component probably had been thalassemia trait cases were parents of children with observed severe Cooley's anemia. In all instances the diagnosis of by previous investigators employing the thalassemia was based on the hematological picture. classical Tiselius procedure in occasional speci- Several individuals who were suspected of having thalas- mens of blood from normal persons (2, 3) and semia were excluded from the study because of un- thalassemia patients (4), but had not been defined certain hematological findings.
    [Show full text]
  • Chapter 03- Diseases of the Blood and Certain Disorders Involving The
    Chapter 3 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50- D89) Excludes2: autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) This chapter contains the following blocks: D50-D53 Nutritional anemias D55-D59 Hemolytic anemias D60-D64 Aplastic and other anemias and other bone marrow failure syndromes D65-D69 Coagulation defects, purpura and other hemorrhagic conditions D70-D77 Other disorders of blood and blood-forming organs D78 Intraoperative and postprocedural complications of the spleen D80-D89 Certain disorders involving the immune mechanism Nutritional anemias (D50-D53) D50 Iron deficiency anemia Includes: asiderotic anemia hypochromic anemia D50.0 Iron deficiency anemia secondary to blood loss (chronic) Posthemorrhagic anemia (chronic) Excludes1: acute posthemorrhagic anemia (D62) congenital anemia from fetal blood loss (P61.3) D50.1 Sideropenic dysphagia Kelly-Paterson syndrome Plummer-Vinson syndrome D50.8 Other iron deficiency anemias Iron deficiency anemia due to inadequate dietary
    [Show full text]
  • Lasker Interactive Research Nom'18.Indd
    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
    [Show full text]